Our data show that treatment of osteosarcoma cells with Nimbolide also decreases the MMP (Figure 2C) as well as alters the expression of members of the Bcl-2 family to increase the ratio of pro-apoptotic to anti-apoptotic Bcl-2 proteins (Figure 2D). This evidence concerns the gene BCL2 and osteosarcoma.